Caspofungin acetate

Key facts

Invented name
  • Cancidas (previously Caspofungin MSD)
  • Cancidas
Active substance
caspofungin acetate
Therapeutic area
Infectious diseases
Decision number
P/30/2008
PIP number
Caspofungin acetate
Pharmaceutical form(s)
  • Powder for concentrate for solution for infusion
  • Powder for solution for infusion
Condition(s) / indication(s)
Fungal infections
Route(s) of administration
Intravenous use
Contact for public enquiries
Merck Sharp & Dohme (Europe) Ltd
Belgium
Tel. +33 180 464 738
E-mail: pip.information@merck.com
Decision type
PM: decision on the application for modification of an agreed PIP
Compliance procedure number
EMEA-C-000010-PIP01-07-M01
Compliance opinion date
04/06/2008
Compliance outcome
positive

Decision

Related content

Topics

How useful was this page?

Add your rating